Association of p53 mutations with progression-free survival (PFS) and overall survival (OS) in EGFR-mutated non-small cell lung cancer (NSCLC) patients (p) treated with erlotinib.
Amaya Gasco
No relevant relationships to disclose
Miguel Angel Molina-Vila
No relevant relationships to disclose
Jordi Bertran-Alamillo
No relevant relationships to disclose
Clara Mayo
No relevant relationships to disclose
Carlota Costa
No relevant relationships to disclose
Ana Gimenez Capitan
No relevant relationships to disclose
Bartomeu Massuti
No relevant relationships to disclose
Carlos Camps
No relevant relationships to disclose
Enric Carcereny Costa
No relevant relationships to disclose
Santiago Viteri Ramirez
No relevant relationships to disclose
Alejandro Martinez-Bueno
No relevant relationships to disclose
Susana Benlloch
No relevant relationships to disclose
Laia Capdevila
No relevant relationships to disclose
Sara Cros
No relevant relationships to disclose
Rut Porta
No relevant relationships to disclose
Felipe Cardenal
No relevant relationships to disclose
Joaquim Bosch
No relevant relationships to disclose
Jose Javier Sanchez
No relevant relationships to disclose
Miquel Taron
No relevant relationships to disclose
Rafael Rosell
No relevant relationships to disclose